Inhibitor Therapeutics, Inc. SEC filings INTI

Inhibitor Therapeutics, Inc. has 724 filings in SEC EDGAR's recent list, going back to Jul 21, 1997. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

Inhibitor Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Shareholder vote results
Sep 18, 2026 Sep 15, 2026
DEF 14A Proxy statement Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
4 Insider transaction Aug 4, 2026 Jul 1, 2026
4 Insider transaction Aug 4, 2026 May 4, 2026
4 Insider transaction Aug 4, 2026 May 4, 2026
4 Insider transaction Aug 4, 2026 May 4, 2026
4 Insider transaction Aug 4, 2026 May 4, 2026
4 Insider transaction Jun 24, 2026 May 4, 2026
4 Insider transaction Jun 1, 2026 May 5, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
Apr 1, 2026 Apr 1, 2026
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Material agreement
Feb 24, 2026 Feb 24, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, Officer or director change
Oct 27, 2025 Oct 24, 2025
UPLOAD Letter from the SEC Sep 15, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
CORRESP Letter to the SEC Jul 22, 2025 —
UPLOAD Letter from the SEC Jul 17, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
4 Insider transaction Apr 10, 2025 Apr 1, 2024
4 Insider transaction Apr 7, 2025 Apr 1, 2024
4 Insider transaction Apr 7, 2025 Apr 1, 2024
4 Insider transaction Apr 7, 2025 Apr 1, 2024
4 Insider transaction Apr 7, 2025 Apr 1, 2024
10-K Annual report Mar 28, 2025 Dec 31, 2024
5 Annual insider ownership Feb 19, 2025 Dec 31, 2024
5 Annual insider ownership Feb 19, 2025 Dec 31, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
4 Insider transaction May 16, 2024 Apr 1, 2024
4 Insider transaction May 16, 2024 Mar 16, 2024
4 Insider transaction May 16, 2024 Apr 1, 2024
4 Insider transaction May 16, 2024 Apr 1, 2024
4 Insider transaction May 16, 2024 Apr 1, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Material agreement, Other events
Dec 14, 2023 Dec 12, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Oct 18, 2023 Oct 13, 2023
4 Insider transaction Aug 29, 2023 Aug 18, 2023
3 Initial insider ownership Aug 29, 2023 May 5, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Aug 29, 2023 Aug 23, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Officer or director change
May 31, 2023 May 31, 2023
SC 13D Ownership over 5% (active) May 23, 2023 —
SC 13G Ownership over 5% (passive) May 23, 2023 —
3 Initial insider ownership May 22, 2023 May 5, 2023
SC 13G Ownership over 5% (passive) May 18, 2023 —
4 Insider transaction May 17, 2023 May 5, 2023
3 Initial insider ownership May 17, 2023 May 5, 2023
4 Insider transaction May 17, 2023 May 5, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
3 Initial insider ownership Dec 22, 2022 Dec 13, 2022
3 Initial insider ownership Dec 22, 2022 Dec 13, 2022
3 Initial insider ownership Dec 22, 2022 Dec 13, 2022
3 Initial insider ownership Dec 22, 2022 Dec 13, 2022
3 Initial insider ownership Dec 22, 2022 Dec 13, 2022
8-K Current report
Material agreement, Agreement ended, Change in control, Officer or director change
Dec 19, 2022 Dec 13, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Other events
Sep 15, 2022 Sep 9, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Jun 3, 2022 Jun 1, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Jan 18, 2022 Jan 13, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-K Annual report Mar 26, 2021 Dec 31, 2020
4 Insider transaction Jan 19, 2021 Jan 15, 2021
8-K Current report
Officer or director change
Jan 6, 2021 Dec 31, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
4 Insider transaction Dec 28, 2020 Dec 22, 2020
8-K Current report
Material agreement, New debt
Dec 17, 2020 Dec 12, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
8-K Current report
Officer or director change
Sep 23, 2020 Sep 17, 2020
4 Insider transaction Sep 21, 2020 Sep 17, 2020
4 Insider transaction Sep 21, 2020 Sep 17, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
4 Insider transaction Jul 20, 2020 Jul 15, 2020
8-K Current report
Officer or director change
Jun 30, 2020 Jun 28, 2020
8-K Current report
Other events
Jun 8, 2020 Jun 4, 2020
8-K Current report
Material agreement, New debt
May 6, 2020 May 3, 2020
10-Q Quarterly report May 1, 2020 Mar 31, 2020
8-K Current report
Officer or director change
Apr 16, 2020 Apr 10, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
4 Insider transaction Mar 24, 2020 Mar 20, 2020
4 Insider transaction Mar 24, 2020 Mar 20, 2020
4 Insider transaction Mar 24, 2020 Mar 20, 2020
4 Insider transaction Mar 24, 2020 Mar 20, 2020
5 Annual insider ownership Feb 10, 2020 Dec 31, 2019
8-K Current report
Officer or director change, Other events
Jan 3, 2020 Dec 31, 2019
4 Insider transaction Dec 16, 2019 Dec 12, 2019
DEF 14C Information statement Dec 5, 2019 Dec 5, 2019
4 Insider transaction Dec 2, 2019 Dec 2, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
3 Initial insider ownership Nov 1, 2019 Oct 30, 2019
8-K Current report
Officer or director change, Other events
Oct 31, 2019 Oct 30, 2019
8-K Current report
Material agreement, Agreement ended
Aug 27, 2019 Aug 21, 2019
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
Aug 20, 2019 Aug 19, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
8-K Current report
Regulation FD disclosure, Other events
Jul 17, 2019 Jul 17, 2019
8-K Current report
Officer or director change
Jul 1, 2019 Jun 30, 2019
8-K Current report
Other events
Jun 19, 2019 Jun 14, 2019
4 Insider transaction Jun 10, 2019 Jun 3, 2019
DEF 14C Information statement Jun 3, 2019 Jun 3, 2019
PRE 14C Filing May 24, 2019 May 24, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
EFFECT Filing Apr 30, 2019 —
POS AM Filing Apr 26, 2019 —
8-K Current report
Other events
Apr 15, 2019 Apr 15, 2019
CT ORDER Filing Apr 1, 2019 —
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Regulation FD disclosure, Other events
Feb 13, 2019 Feb 11, 2019
4 Insider transaction Feb 5, 2019 Feb 3, 2019
4 Insider transaction Feb 5, 2019 Feb 3, 2019
4 Insider transaction Feb 5, 2019 Feb 3, 2019
4 Insider transaction Feb 5, 2019 Feb 3, 2019
4 Insider transaction Jan 24, 2019 Jan 15, 2019
DEF 14C Information statement Jan 8, 2019 Dec 21, 2018
8-K Current report
Material agreement, Officer or director change
Dec 31, 2018 Dec 31, 2018
PRE 14C Filing Dec 28, 2018 Dec 21, 2018
4 Insider transaction Dec 26, 2018 Dec 20, 2018
4 Insider transaction Dec 26, 2018 Dec 20, 2018
DEF 14C Information statement Dec 21, 2018 Dec 21, 2018
4 Insider transaction Dec 19, 2018 Jul 15, 2018
SC 13D/A Amended ownership over 5% (active) Dec 19, 2018 —
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
Dec 17, 2018 Dec 17, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Regulation FD disclosure
Nov 5, 2018 Nov 5, 2018
SC 13D/A Amended ownership over 5% (active) Nov 5, 2018 —
4 Insider transaction Aug 31, 2018 Aug 30, 2018
10-Q Quarterly report Jul 23, 2018 Jun 30, 2018
8-K Current report
Unregistered share sale, Other events
Jul 10, 2018 Jul 6, 2018
4 Insider transaction Jul 6, 2018 Jul 5, 2018
SC 13D/A Amended ownership over 5% (active) Jul 6, 2018 —
10-Q Quarterly report May 1, 2018 Mar 31, 2018
EFFECT Filing Apr 17, 2018 —
POS AM Filing Apr 4, 2018 —
4 Insider transaction Mar 15, 2018 Mar 13, 2018
4 Insider transaction Mar 15, 2018 Mar 13, 2018
4 Insider transaction Mar 15, 2018 Mar 13, 2018
4 Insider transaction Mar 15, 2018 Mar 13, 2018
4 Insider transaction Mar 15, 2018 Mar 13, 2018
4 Insider transaction Mar 15, 2018 Mar 13, 2018
10-K Annual report Feb 16, 2018 Dec 31, 2017
4 Insider transaction Feb 12, 2018 Dec 19, 2017
4 Insider transaction Feb 12, 2018 Dec 19, 2017
CT ORDER Filing Jan 22, 2018 —
4 Insider transaction Jan 11, 2018 Jan 10, 2018
SC 13D/A Amended ownership over 5% (active) Jan 11, 2018 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 11, 2018 Jan 8, 2018
8-K Current report
Shareholder vote results
Dec 20, 2017 Dec 18, 2017
DEF 14A Proxy statement Nov 13, 2017 Dec 18, 2017
10-Q Quarterly report Oct 31, 2017 Sep 30, 2017
8-K Current report
Other events
Oct 5, 2017 Oct 5, 2017
10-Q Quarterly report Jul 31, 2017 Jun 30, 2017
SC 13D/A Amended ownership over 5% (active) Jul 28, 2017 —
8-K Current report
Other events
Jul 27, 2017 Jul 25, 2017
4 Insider transaction Jul 19, 2017 May 4, 2017
4 Insider transaction Jul 19, 2017 May 4, 2017
4 Insider transaction Jul 12, 2017 Jun 30, 2017
8-K Current report
Other events
May 30, 2017 May 30, 2017
10-Q Quarterly report May 8, 2017 Mar 31, 2017
EFFECT Filing Apr 25, 2017 —
POS AM Post - effective amendment no. 1 to form s-1 Apr 21, 2017 —
4 Insider transaction Mar 10, 2017 Mar 8, 2017
4 Insider transaction Mar 10, 2017 Mar 8, 2017
4 Insider transaction Mar 10, 2017 Mar 8, 2017
4 Insider transaction Mar 10, 2017 Mar 8, 2017
4 Insider transaction Mar 10, 2017 Mar 8, 2017
10-K Annual report Feb 17, 2017 Dec 31, 2016
8-K Current report
Regulation FD disclosure
Jan 24, 2017 Jan 24, 2017
3 Initial insider ownership Dec 6, 2016 Nov 30, 2016
DEF 14C Information statement Dec 5, 2016 Dec 5, 2016
8-K Current report
Officer or director change, Other events
Dec 2, 2016 Nov 30, 2016
SC 13D/A Amended ownership over 5% (active) Dec 2, 2016 —
3 Initial insider ownership Nov 30, 2016 Nov 22, 2016
8-K Current report
Material agreement, Officer or director change
Nov 28, 2016 Nov 22, 2016
SC 13D/A Amended ownership over 5% (active) Nov 28, 2016 —
SC 13D/A Amended ownership over 5% (active) Nov 16, 2016 —
4 Insider transaction Nov 15, 2016 Nov 15, 2016
8-K Current report
Change in control
Nov 8, 2016 Nov 2, 2016
SC 13D/A Amended ownership over 5% (active) Nov 8, 2016 —
4 Insider transaction Nov 7, 2016 Nov 4, 2016
10-Q Quarterly report Oct 31, 2016 Sep 30, 2016
S-8 Employee stock plan registration Oct 24, 2016 —
10-Q Quarterly report Aug 12, 2016 Jun 30, 2016
424B3 Prospectus Jul 26, 2016 —
EFFECT Filing Jul 22, 2016 —
CORRESP Letter to the SEC Jul 21, 2016 —
S-1/A Amended registration statement Jul 21, 2016 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INTI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1042418
Former names
HedgePath Pharmaceuticals, Inc. (until Aug 12, 2019); COMMONWEALTH BIOTECHNOLOGIES INC (until May 20, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.